tiprankstipranks
Medpace Holdings (MEDP)
NASDAQ:MEDP
US Market

Medpace Holdings (MEDP) Drug Pipeline

657 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
[18F]Fpyqcp
Colorectal Cancer, Epithelial Ovarian Cancer, Pancreatic Ductal Adenocarcinoma, Gastric Cancer, Invasive Lobular Breast Carcinoma
Phase I/II
Recruiting
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Feb 10, 2026
177Lu-Betabart
Small Cell Lung Cancer (Sclc ), Head &Amp; Neck Squamous Cell Carcinoma (Hnscc), Colorectal Cancer, Endometrial Cancer, Cervical Cancer, Ovarian Cancer, Nsclc (Non-Small Cell Lung Cancer), Castration-Resistant Prostate Cancer (Crpc), Esophageal Squamous Cell Carcinoma (Escc), Tnbc, Triple Negative Breast Cancer
Phase I/II
Recruiting
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Sep 11, 2025
177Lu-Tlx250
Renal Cell Carcinoma (Rcc), Ccrcc, Renal Cell Carcinoma (Kidney Cancer), Renal Cell Cancer Metastatic, Renal Cell Cancer, Recurrent, Clear Cell Renal Cell Cancer (Ccrcc)
Phase III
Not Yet Recruiting
Study of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC
Aug 18, 2025
Rad101
Brain Metastases From Solid Tumors
Phase II
Recruiting
Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases
Dec 19, 2024
Lutetium Rhpsma 10.1 And Pluvicto
Metastatic Prostate Cancer
Early Phase I
Terminated
A Dosimetry Study of Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto®) in Patients With Non-curative Metastatic Prostate Cancer
Jun 17, 2024
Sevasemten
Becker Muscular Dystrophy
Phase II
Enrolling By Invitation
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Sep 27, 2023
Azeliragon
Glioblastoma
Phase II
Active Not Recruiting
Azeliragon in MGMT Unmethylated Glioblastoma
Aug 03, 2023
Tnx-103
Pulmonary Hypertension
Phase III
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Aug 01, 2023
Chs-006, Toripalimab
Hepatocellular Carcinoma, Advanced Solid Tumor, Non-small Cell Lung Cancer
Phase I
Terminated
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced Solid Tumors
Jan 02, 2023
Sevasemten 10 Mg, Sevasemten 5 Mg, Sevasemten 12.5 Mg
Becker Muscular Dystrophy
Phase II
Active Not Recruiting
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Mar 14, 2022

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Medpace Holdings (MEDP) have in its pipeline
      MEDP is currently developing the following drugs: [18F]Fpyqcp, 177Lu-Betabart, 177Lu-Tlx250. These drug candidates are in various stages of clinical development as the company works toward FDA approval.